TGFβ1 is tumor-suppressive in early cancer development, but, in established tumors, it allows for tumor survival by creating immunosuppressive microenvironments, by increasing angiogenesis, and by regulating epithelial-to-mesenchymal transition [56,57,58,59]. This evidence concerns the gene TGFB1 and cancer.